期刊文献+

免疫印迹法检测抗胆碱能毒蕈碱受体3抗体及其在干燥综合征诊断中的意义 被引量:9

The detection of autoantibodies against type 3 muscarinic acetylcholine receptor in Sjgren′s syndrome
原文传递
导出
摘要 目的建立免疫印迹法(WB)检测抗毒蕈碱受体3(M3受体)抗体的方法,探讨该抗体对干燥综合征(SS)诊断的意义。方法建立WB测定抗M3受体抗体的方法,检测80例SS患者、80例其他风湿性疾病及40名正常对照者血清中的抗M3受体抗体,并分析该抗体与SS的临床及实验室指标的关系。结果抗M3受体抗体在80例SS患者中的阳性率为83.8%(67/80),而在系统性红斑狼疮(SLE)及正常人中分别为5.0%(2/40)和2.5%(1/40),类风湿关节炎(RA)中无1例阳性。抗M3受体抗体对SS的敏感性和特异性分别为83.8%和97.5%,阳性预测值为95.7%,阴性预测值为90.0%。抗M3受体抗体在抗SSA抗体、抗SSB抗体、琢-胞衬蛋白抗体阴性的SS患者血清中的阳性率分别为80.0%、82.5%及81.2%。该抗体在抗SSA抗体、抗SSB抗体及琢-胞衬蛋白抗体阳性的SS患者血清中的阳性率分别为87.5%、88.2%及85.4%。抗M3受体抗体阳性的SS患者与该抗体阴性的SS患者在口干、眼干、脏器受累的发生率,IgG、IgA、血沉(ESR)升高及抗核抗体(ANA)、类风湿因子(RF)阳性率方面无统计学意义。结论利用sf9细胞表达的重组M3受体蛋白可以检测SS患者血清中的抗M3受体抗体。该抗体是一种对SS诊断较为特异的标记性抗体之一。 Objective To detect anti-M3 autoantibodies in Sjgren′s syndrome (SS) patients and to explore its association with clinical manifestation. Methods Anti-M3 autoantibodies were tested in 80 patients with SS, 80 with other rheumatic diseases and 40 normal controls using Western blot. The correlation between anti-M3 autoantibodies and clinical data of SS was analyzed. Results {1}The positive rate of anti-M3 antibodies was 83.8% in SS, 2.5% in other rheumatic diseases and 2.5% in normal controls. {2}Its sensitivity was 83.8% and specificity was 97.5% in SS with a positive predictive rate of 95.7% and negative prediction rate of 90.0%. {3}The positive rate of anti-M3 antibodies was 80.0%, 82.5% and 81.2% in SS with SSA, SSB and ?琢-Fodrin antibodies negative group, and 87.5%, 88.2% and 85.4% respectively in above antibodies positive group 4. The incidence of organ involvement, IgG, IgA and ESR elevation was not significantly different in anti-M3 antibodies positive and negative group. There was no significant difference in dry eye and dry mouth between antibody positive and negative group. Conclusion Human recombinant M3 muscarinic receptor expressed in sf9 cells can be used to detect anti-M3 autoantibodies in the serum from SS patient. The antibody may be a new and specific serum maker for the diagnosis of SS.
出处 《中华风湿病学杂志》 CAS CSCD 2005年第7期409-412,共4页 Chinese Journal of Rheumatology
关键词 免疫印迹法 抗胆碱能毒蕈碱受体3 抗体 干燥综合征 M3受体 免疫性疾病 Sjgren′s syndrome Diagnostic techniques and procedures Anti-M3 autoantibody
  • 相关文献

参考文献10

  • 1Bacman S, Sterin-Borda L, Camusso JJ, et al. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjogren's syndrome. Clin Exp Immunol, 1996, 104: 454-459.
  • 2Bacman S, Perez LC, Sterin BL, et al. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren's syndrome. Invest Ophthalmol Vis Sci,1998, 39: 151-156.
  • 3Bacman'S, Berra A, Sterin BL, et al. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjogren's syndrome.Invest Ophthalmol Vis Sci, 2001, 42: 321-327.
  • 4Vitali C, Bombardieri S, Jonsson R, et al. Classfication criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis, 2002, 61: 554-558.
  • 5何菁,李晶,栗占国,陈巧林.抗α-胞衬蛋白多肽抗体在干燥综合征诊断中的意义[J].中华风湿病学杂志,2003,7(10):600-603. 被引量:33
  • 6Nguyen KH, Brayer J, Cha S, et al. Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice. Arthritis Rheum, 2000, 10: 2297-2306.
  • 7Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome. Arthritis Rheum, 2000, 7:1647-1654.
  • 8Cavill D, Waterman SA, Gordon TP. Failure to detect antibodies to extracellular loop peptides of the muscarinic M3 receptor in Primary Sjogren's syndrome. J Rheumatol, 2002, 29: 1342-1344.
  • 9Tobin AB, Nahorski SR. Rapid agonist-mediated phosphorylation of M3-muscarinic receptors revealed by immunoprecipitation. JBiol Chem, 1993, 268: 9817-9823.
  • 10Beroukas D, Goodfellow R, Hiscock J, et al. Up-regulation of M3-muscarinic receptors in labial salivary gland acini in primary Sjogren's syndrome. Lab Invest, 2002, 82: 203-210.

二级参考文献11

  • 1Haneji N, Nakamura T,Takio K, et al. Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science, 1997,276 : 604-607.
  • 2Janicke RU, Ng P, Sprengart ML, et al. Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apopto.sis. J Biol Chem, 1998,273 : 15540-15545.
  • 3Witte T,Matthias T,Arnett FC,et al. IgA and IgG Autoantibodies against A-Fodrin a.s markers for Sj6gren's syndrome. J Rheumatol, 2000,27 : 2617-2620.
  • 4Harris AS, Crall DE, Morrow JS. Calmodulin regulates fodrin susceptibility to cleavage by calcium-dependent protease. J 13iol Chem, 1989,264 : 17401-17408.
  • 5Haneji N, Nakamura T,Takio K,et al. Identification of alpha-fodrin antilxxtiex in Sjogren's syndrome in children. J Rheumatol, 2001,28: 860.
  • 6Adams MI), Kelley JM, Gocayne JD, et al. Complementary DNA sequencing: expressed sequence tags and human genome project, Science, 1991,252:1651-1656.
  • 7Masataka K, Tetsumh O, Yoko O, et al. Autoantibodiee to the amino-terminal fragment of a-fodrin expressed in glandular epithelial cells in patients with Sjogren' s syndrome. J Immunol, 2001, 167 : 5449-5456.
  • 8McMahon AP,Giebelhaus DH,Champion JE, et al. cDNA cloning, sequencing and chromosome mapping of a non-erythroid spectrin, human alpha-Fodrin. Differentiation, 1987,34:68-78.
  • 9Nakano M, Nogami S, Sato S, et al. Interaction of syntaxin with alpha-fodrin,a major component of the submembranous cytoskeleton. Biochem Biophys Res Commun, 2001,288:468-475.
  • 10Inoue H, Tsubota K, Ono M, et al. Possible involvement of EBVmediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome. J Immunol, 2001,166: 5801-5809.

共引文献32

同被引文献76

  • 1张乃峥,施全胜.原发性干燥综合征的流行病学调查[J].中华内科杂志,1993,32(8):522-523. 被引量:46
  • 2刘湘源,李胜光,黄烽.生物制剂治疗系统性红斑狼疮的研究进展[J].中华全科医师杂志,2006,5(1):32-34. 被引量:2
  • 3焉传祝.特发性炎性肌病的免疫病理及诊断[J].中华神经科杂志,2006,39(4):217-219. 被引量:5
  • 4Atina S, Marie WH. Local production of Ro/SSA and La/SSB autoantibodies in the target organ coincides with high levels of circulating antibodies in sera of patients with Sjogren's syndrome. Scand J Rheumatol, 2003, 32: 79-82.
  • 5Alspaugh MA, Tan EM. Antibodies to cellular antigens in Sjugren's syndrome, J Clin Invest, 1975, 55: 1067-1073.
  • 6Harley JB, Alexander EL, Bias WB, et al. Anti-Ro (SSA) and anti-La (SSB) in patients with Sjogren's syndrome. Arthritis Rheum, 1986, 29: 196-206.
  • 7Yamamoto H, Sims N, Macauley SP, et al. Alterations in the secretory response of non-obese diabetic mice to muscarinic receptor stimulation. Clin Immunol Immunopathol, 1996, 75: 245-255.
  • 8Bacman S, Borda S, Camusso JJ, et al. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjogren's syndrome. Clin Exp Immunol, 1996, 104: 545-549.
  • 9Bacman S, Sterin-Borda L, Camusso U, et al. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren's syndrome. Invest Ophthalmol Vis Sci, 1998, 39: 151-156.
  • 10Bonner TI, Buckley NJ, Young AC, et al. Identification of a family of muscarinic acetlycholine receptor genes. Science, 1987, 237: 527-532.

引证文献9

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部